Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Eur Respir J. 2012 Jan 12;40(2):386–393. doi: 10.1183/09031936.00177411

Table 2.

Characteristics of sample used to examine objective sleepiness using the Multiple Sleep Latency Test (n=1846)

Characteristic Females
(n=814 MSLT studies)
Males
(n=1032 MSLT studies)
All
AHI < 15 AHI ≥15
or CPAP
AHI < 15 AHI ≥15 or
CPAP
Sample size 735 79 836 196 1846
Age (years) mean(range) 51 (31–73) 54 (35–68) 52 (31–72) 55 (33–71) 52 (31–73)
Body Mass Index (Kg/m2) 31 (7) 42 (9) 29 (5) 35 (7) 31 (7)
MSLT (mins) 11 (5) 10 (6) 9 (5) 9 (5) 10 (5)
MSLT ≤5 mins, n (%) 109 (15) 19 (24) 181 (22) 53 (27) 362 (20)
Habitual sleep time (hours) 7 (1) 7 (1) 7(1) 7 (1) 7 (1)
Nap per week (hours) 1 (3) 2 (3) 2 (2) 2 (3) 2 (3)
Depression*, n (%) 217 (30) 27 (35) 142 (17) 38 (20) 424 (23)
Comorbid conditions, n (%) 30 (4) 4 (5) 58 (7) 30 (15) 122 (7)
Stroke, n (%) 9 (1) 2 (3) 1 (0.1) 7 (4) 19 (2)
Heart Failure, n (%) 5 (1) 0 (0) 4 (0.5) 2 (1) 11 (1)
Cardiovascular disease**, n (%) 19 (3) 3 (4) 55 (7) 23 (12) 100 (5)
Current Smoker, n (%) 108 (15) 6 (8) 134 (16) 26 (16) 274 (15)
Alcoholic drinks per week, median (range) 1 (0–36) 0 (0–14) 2 (0–98) 2 (0–29) 2 (0–98)
Caffeinated drinks per day, mean (sd) 3 (2) 2 (2) 3 (3) 4 (3) 3 (3)
CPAP use, n (%) NA 26 (33) NA 54 (28) 80 (4)

These data are reported on number of sleep studies, with most subjects contributing multiple studies. Variables are reported as mean (sd) unless otherwise stated.

*

Defined as using antidepressant medication or ZUNG depression scale ≥ 50

**

Heart attack, coronary artery disease, or cardiovascular surgical procedure